NFKB1 and depressive symptom measurement: In conclusion, taVNS ameliorates depression‐like behaviors in CUMS model rats, inhibits the hypothalamic microglia activity and increases α7nAchR expression in the hypothalamus, which in turn activates the JAK2/STAT3 signaling pathway and inhibits the NF‐κB signaling pathway.